The LCAT gene helps turn free cholesterol into a form that can be carried in high density lipoprotein, or HDL, often called good cholesterol. This gene helps your body clear cholesterol more effectively from the blood and tissues. If the LCAT gene does not work properly, people may develop very low HDL, cloudy corneas that blur vision, anemia, and kidney problems. Inherited harmful variants can cause familial LCAT deficiency or the milder fish-eye disease.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the functional parts of cells. Others mainly help direct when certain processes occur, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
LCATGene function
What if the gene works
The LCAT gene helps make an enzyme that changes cholesterol into a form your body can carry and store more easily. This supports normal HDL function and helps move cholesterol from the blood to the liver.
Risk
What if the gene does not work
Variants in the LCAT gene can cause a spectrum from fish-eye disease to familial LCAT deficiency. People may have cloudy corneas and very low HDL cholesterol, while more severe variants can also lead to anemia and kidney disease.
Treatment
What does that mean for your treatment
At present, no LCAT specific treatment or guideline based drug choice is established for people with pathogenic variants in the LCAT gene. The LCAT gene is being studied as a treatment target, including lab made LCAT enzyme replacement, but this remains investigational.
Conditions associated with LCAT
Gene function
What if the gene works
Healthy cholesterol handling depends on a steady flow of fats between blood and tissues. The LCAT gene helps shape HDL, often called good cholesterol, so it can carry cholesterol through the bloodstream. This supports everyday blood fat balance and the return of extra cholesterol to the liver.
Its protein changes surface cholesterol on HDL into a packed form that moves inside the particle. This turns small, flat HDL into a rounder carrier that can hold more cholesterol.
By helping HDL mature, the LCAT gene supports the trip of extra cholesterol from body tissues back to the liver. This is a central part of what the LCAT gene does in cholesterol transport.
The LCAT gene works mainly in plasma, the liquid part of blood, while linked mostly to HDL. This helps cholesterol stay organized on blood particles and move through circulation in a controlled way.
Its protein also shifts a fatty component from the particle surface while it processes cholesterol. This refreshes the outer layer of HDL so the particle can keep traveling and collecting more cholesterol.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect the natural range of genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LCAT gene can affect how the body processes cholesterol by making the LCAT protein unstable, less active, or less able to attach to HDL particles. Some variants leave partial activity, while more disruptive variants can nearly eliminate enzyme function. This functional range helps explain why some people have milder findings, such as fish eye disease, and others develop the broader features of familial LCAT deficiency.
How variants are linked to conditions
Pathogenic variants in the LCAT gene can cause familial LCAT deficiency and fish-eye disease, two inherited conditions that mainly affect the eyes, kidneys, and cholesterol levels. In practice, LCAT gene variants linked to conditions are usually rare, and finding a disease-causing variant can confirm the diagnosis. Some people develop cloudy corneas, kidney problems, or unusual cholesterol test results, although the pattern and severity can vary.
A variant is not necessarily a diagnosis
Genetic variants are a normal and common feature of human biology in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LCAT, risk is mostly shaped by inheritance: people who inherit disease-causing changes in both copies of the gene are much more likely to develop the condition, while carriers with one changed copy usually do not. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower the genetic risk itself, although regular follow-up can help catch kidney, eye, and cholesterol-related problems early.
Inheritance of LCAT variants
For families trying to understand how variants of the LCAT gene are inherited, the established pattern is autosomal recessive. This means a person usually develops an LCAT related condition only when they inherit one disease causing variant from each parent. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without either variant. Because the LCAT gene is on chromosome 16, this pattern is the same for males and females.
What does my LCAT result mean for my family?
For LCAT, the family pattern is usually recessive, so close relatives can sometimes carry the same gene change without having symptoms. Brothers and sisters may have the condition or be carriers, while parents are often carriers. Children of someone with two changed LCAT copies will usually be carriers, and they could have the condition only if the other parent also carries an LCAT change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for LCAT variants usually uses a blood or saliva sample. A lab reads the LCAT gene, often with sequencing and sometimes deletion or duplication analysis, to look for changes linked to low HDL cholesterol and related findings. Results can confirm an inherited LCAT condition or help rule one out.
When should I consider getting a genetic test?
You may want to consider LCAT genetic testing if you or a close family member has very low HDL, often called “good” cholesterol, cloudy areas in the front of the eye, unexplained anemia, or kidney disease that suggests an inherited LCAT-related condition. It can also help clarify a family history of this rare condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when viewed together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug works well for one person, does little for another, or causes more side effects in someone else. Small inherited differences can change how the body breaks down a medicine, moves it through the bloodstream, or responds to it at its target. These differences are common and can influence both how well a treatment works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way a person responds to medications. It studies connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more personalized. If you want to learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the LCAT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects are more likely. For now, general questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Researchers began identifying the LCAT gene through studies of blood fats in the 1960s, when scientists recognized an enzyme that changed how cholesterol traveled in the bloodstream. In the following decades, rare families with very low enzyme activity helped link inherited changes to a distinct human condition, including what came to be known as familial LCAT deficiency and fish-eye disease. From these first observations, research expanded steadily. By the late 20th century, the LCAT gene had become part of the broader story of lipid research, helping scientists map inherited causes of unusual cholesterol patterns. Its history is closely tied to advances in laboratory testing, family studies, and a growing understanding of inherited lipid conditions.